About
First Light is an editorial publication on life science technology, AI biology, and the markets forming around them. It looks for useful, early signals before they become obvious and well-known.
Written from inside the industry, First Light brings customer behavior, technical literacy, and user/operator judgement to company and technology analysis. The publication separates aspirations and assumptions from evidence, focuses on what can become usable technically, commercially and practically, and explains what matters in straightforward language.
Coverage centers around four areas: genomics, proteomics, AI biology and diagnostics. Field Notes cover conferences, frameworks, and observations.

About Dale Yuzuki
I'm Dale Yuzuki, and I've spent over two decades in the life sciences tools industry, with commercial and marketing roles at Illumina, Thermo Fisher Scientific / Life Technologies, and adjacent companies. I sold the first Illumina Genome Analyzers to the US National Institutes of Health in 2007; I later sold capital equipment and reagents to oncology and genetic disease assay markets for seven years before moving into marketing leadership.
Most recently I led marketing at two major multiplex immunoassay companies.
The thread throughout the career has been a willingness to learn the science deeply enough to write about it credibly, including citing the primary literature, and then translate that science into the commercial language that scientific leaders, laboratory directors, and clinical buyers actually use to make purchase decisions.
Over the past year I have worked as a hands-on AI practitioner inside a life science commercial organization, including on an AI Leadership Team and AI Council. That experience shapes how First Light covers AI Biology: from the perspective of someone building with these tools, and not just observing them.
First Light is where I surface my experience and new learning to public editorial content. I also advise through Silent Valley Consulting.
Views expressed here are my own.